C‐reactive protein as a regulator of autoimmunity and inflammation

Abstract

Metal acetylacetonates are effective latent catalysts for epoxy/anhydride systems. A screen test on the catalytic behavior of metal acetylacetonate shows that this system offers a wide range of curing latency and material properties. It can be inferred that the curing behavior is closely related to the bonding strength of the metal ion to the ligand. Isothermal kinetic study on the catalytic behavior of metal chelates with first‐row transition metal ions is conducted and analyzed by using an autocatalytic model. It is found that the activation energy of the system containing the divalent metal chelates follows the Irving and Williams rule. The activation energies of the reaction obtained in the kinetic study are compared with the dissociation energies of the metal/ligand bond and the results are discussed. © 2002 Wiley Periodicals, Inc. J Appl Polym Sci 86: 1572–1579, 2002

Increasing levels of saliva alpha amylase in electrohypersensitive (EHS) patients

“…High levels of serum CRP have been correlated to cardiovascular risks and other inflammatory or immune diseases (Tracy et al 1997;Du Clos 2003). Recently, elevated levels of CRP and hsp70 have been detected in frequent users of mobile phones (Balakrishnan et al 2014).…”

Biomarkers: A Definite Plus in Pneumonia

“…Once the stimulus is no longer present, the CRP value starts falling with a half-life of 19 hours [3]. For many years, the value of CRP in healthy individuals has been considered to be less than 0.5 μ g/mL [4]. However, in a large study carried out in two different countries (comprising of 2291 males and 2203 females), Hutchinson et al found that CRP increases as the age of individuals increases [5].…”

Crystal structures for short-chain pentraxin from zebrafish demonstrate a cyclic trimer with new recognition and effector faces

“…Currently, CRP and SAP are extensively used as biomarkers of various diseases and are targeted in cardiovascular disease treatment (Pepys et al, 2006). These proteins also have potentially broader applications in important diseases, including inflammation, infection and tissue damage (Du Clos, 2003;Ng et al, 2007;Xia and Samols, 1997).…”